203 related articles for article (PubMed ID: 19762360)
1. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
Svenungsson E; Gustafsson J; Leonard D; Sandling J; Gunnarsson I; Nordmark G; Jönsen A; Bengtsson AA; Sturfelt G; Rantapää-Dahlqvist S; Elvin K; Sundin U; Garnier S; Simard JF; Sigurdsson S; Padyukov L; Syvänen AC; Rönnblom L
Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.
Lundström E; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Elvin K; Sturfelt G; Nordmark G; Bengtsson AA; Sundin U; Källberg H; Sandling JK; Syvänen AC; Klareskog L; Gunnarsson I; Rönnblom L; Padyukov L; Svenungsson E
Ann Rheum Dis; 2013 Jun; 72(6):1018-25. PubMed ID: 22893315
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Atsumi T; Kobashi G; Takahashi H;
J Rheumatol; 2009 Oct; 36(10):2195-203. PubMed ID: 19684152
[TBL] [Abstract][Full Text] [Related]
4. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
Kobayashi S; Ikari K; Kaneko H; Kochi Y; Yamamoto K; Shimane K; Nakamura Y; Toyama Y; Mochizuki T; Tsukahara S; Kawaguchi Y; Terai C; Hara M; Tomatsu T; Yamanaka H; Horiuchi T; Tao K; Yasutomo K; Hamada D; Yasui N; Inoue H; Itakura M; Okamoto H; Kamatani N; Momohara S
Arthritis Rheum; 2008 Jul; 58(7):1940-6. PubMed ID: 18576330
[TBL] [Abstract][Full Text] [Related]
5. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
[TBL] [Abstract][Full Text] [Related]
6. Variation in STAT4 is associated with systemic lupus erythematosus in a Finnish family cohort.
Hellquist A; Sandling JK; Zucchelli M; Koskenmies S; Julkunen H; D'Amato M; Garnier S; Syvänen AC; Kere J
Ann Rheum Dis; 2010 May; 69(5):883-6. PubMed ID: 19717398
[TBL] [Abstract][Full Text] [Related]
7. Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
Yang W; Ng P; Zhao M; Hirankarn N; Lau CS; Mok CC; Chan TM; Wong RW; Lee KW; Mok MY; Wong SN; Avihingsanon Y; Lee TL; Ho MH; Lee PP; Wong WH; Lau YL
Genes Immun; 2009 Apr; 10(3):219-26. PubMed ID: 19225526
[TBL] [Abstract][Full Text] [Related]
8. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians.
Palomino-Morales RJ; Rojas-Villarraga A; González CI; Ramírez G; Anaya JM; Martín J
Genes Immun; 2008 Jun; 9(4):379-82. PubMed ID: 18432273
[TBL] [Abstract][Full Text] [Related]
9. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
11. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
[TBL] [Abstract][Full Text] [Related]
13. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
Suarez-Gestal M; Calaza M; Dieguez-Gonzalez R; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Marenco JL; Herrero-Beaumont G; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Ortiz AM; Carreño L; Cañete JD; Caliz R; Blanco FJ; Balsa A; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2009 Sep; 60(9):2558-64. PubMed ID: 19714582
[TBL] [Abstract][Full Text] [Related]
15. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
[TBL] [Abstract][Full Text] [Related]
16. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
[TBL] [Abstract][Full Text] [Related]
18. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus.
Johansson M; Arlestig L; Möller B; Rantapää-Dahlqvist S
Arthritis Rheum; 2005 Jun; 52(6):1665-9. PubMed ID: 15934088
[TBL] [Abstract][Full Text] [Related]
19. p21 gene polymorphisms in systemic lupus erythematosus.
Kong EK; Chong WP; Wong WH; Lau CS; Chan TM; Ng PK; Song YQ; Mak W; Lau YL
Rheumatology (Oxford); 2007 Feb; 46(2):220-6. PubMed ID: 16837471
[TBL] [Abstract][Full Text] [Related]
20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
